MGS acquires Knudsen Plast
MGS, a prominent player in the healthcare manufacturing sector, has acquired the Danish injection molding company Knudsen Plast for an undisclosed amount. This move is strategically aimed at bolstering MGS’s capabilities in Europe by leveraging Knudsen Plast’s operations in Denmark and Slovakia. The acquisition promises expanded cleanroom capacity and enhanced supply chain proximity, vital in supporting MGS's European clients more effectively.
According to MGS President and CEO Paul Manley, the transaction allows MGS to integrate Knudsen Plast’s renowned technical expertise and strong quality systems with its own comprehensive offerings. MGS is noted for its vertically integrated healthcare solutions, including design, development, tooling, automation, and manufacturing services. This acquisition will enable MGS to assist healthcare innovators in accelerating development processes and strengthening supply chains while scaling production.
The addition of Knudsen Plast is expected to fortify MGS's standing in the healthcare manufacturing sector by enhancing its injection molding capabilities and expanding its global workforce to approximately 1,600 employees across 13 facilities. This strategic expansion aligns with MGS's recent operational developments, including the launch of a new drug delivery device manufacturing facility, further cementing its position as a leader in healthcare solutions.
The healthcare manufacturing sector is characterized by rigorous quality standards and an ever-increasing demand for innovation. With Knudsen Plast’s track record of delivering high-quality, innovative solutions, MGS is well-positioned to meet evolving industry requirements. The acquisition also signifies a potential shift in regional industry dynamics, providing MGS with expanded resources to better compete with other firms in the contract development and manufacturing organization space.
Looking forward, MGS will focus on the integration process to fully realize the operational synergies and benefits promised by the acquisition. While the financial terms remain private, successful integration could set the stage for further growth and expansion in the European market. The transaction is expected to provide new development opportunities for employees, fostering an environment where both companies can thrive under the expanded operational capacity and expertise base.
Deal timeline
This transaction is classified in Healthcare. Figures and status may change as sources update.